Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model
- 1 March 1995
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 21 (3) , 492-498
- https://doi.org/10.1016/s0741-5214(95)70292-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboonsJournal of Vascular Surgery, 1993
- Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.Circulation, 1993
- Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.Circulation, 1991
- Hirudin interruption of heparin-resistant arterial thrombus formation in baboonsBlood, 1991
- Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trialJournal of Vascular Surgery, 1991
- Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.Circulation, 1990
- Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass graftingJournal of the American College of Cardiology, 1990
- Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.Circulation, 1989
- Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.Circulation, 1988